Clinical Trial Update: A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating apatinib as second-line treatment for advanced intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: UNKNOWN